The market is growing…
Nearly 12 million adults have been diagnosed with COPD in the U.S.
Asthma affects nearly 334 million people worldwide.
The adoption of O2 therapy is increasing and we saw a need for a change. Something to help these millions of people that assists with controlled flow, efficient dosing, faster response rates, and greater durability and reliability. We wanted oxygen therapy to feel as natural as possible and to take the guesswork out of the process.
Innovative Solution for Automated Supplemental Oxygen Control
Our device, MoblO2, is for people with advanced lung disease and have been prescribed long-term oxygen therapy (LTOT). It provides reliable, continuous monitoring and flow variability of the supplemental oxygen supply to assure stable oxygen saturation levels both efficiently and effectively in any setting.
To us, it is about restoring hope
Our desire is to restore a person’s hope and spirit while improving the quality of their life for both the patient and their caregiver by providing a smart technology device that takes the worry out of oxygen management.